| Bioactivity | BMAP-27 is an antimicrobial peptide capable of disrupting the membrane integrity of microorganisms. Due to its membrane permeability, MAP-27 has inhibitory activity against both bacteria and cancer cells[1]. |
| Name | BMAP-27 |
| CAS | 184870-30-2 |
| Sequence | Gly-Arg-Phe-Lys-Arg-Phe-Arg-Lys-Lys-Phe-Lys-Lys-Leu-Phe-Lys-Lys-Leu-Ser-Pro-Val-Ile-Pro-Leu-Leu-His-Leu-NH2 |
| Shortening | GRFKRFRKKFKKLFKKLSPVIPLLHL-NH2 |
| Formula | C158H263N45O27 |
| Molar Mass | 3225.06 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yang S, et al. Structural analysis and mode of action of BMAP-27, a cathelicidin-derived antimicrobial peptide. Peptides. 2019 Aug;118:170106. |
BMAP-27
CAS: 184870-30-2 F: C158H263N45O27 W: 3225.06
BMAP-27 is an antimicrobial peptide capable of disrupting the membrane integrity of microorganisms. Due to its membrane
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.